The Pruritus Therapeutics Market is projected to surpass USD 19.98 Billion by 2028, up from USD 12.40 Billion in 2020, demonstrating a Compound Annual Growth Rate (CAGR) of about 6.2% throughout the forecast period. The increasing prevalence of skin diseases is expected to be a key factor propelling the Pruritus Therapeutics Market. Pruritus is often linked to primary skin disorders such as...